Search details
1.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Ann Rheum Dis
; 82(10): 1258-1270, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37640450
2.
The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas.
Int J Mol Sci
; 24(13)2023 Jun 30.
Article
in English
| MEDLINE | ID: mdl-37446111
3.
Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes: A survey of 1075 cases from EUROAPS registry∗.
Eur J Anaesthesiol
; 38(9): 916-922, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34397526
4.
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
Rheumatology (Oxford)
; 59(6): 1306-1314, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-31580459
5.
Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry.
Rheumatology (Oxford)
; 60(12): 5883, 2021 Dec 01.
Article
in English
| MEDLINE | ID: mdl-34672326
6.
Deciphering the immunological interactions: targeting preeclampsia with Hydroxychloroquine's biological mechanisms.
Front Pharmacol
; 15: 1298928, 2024.
Article
in English
| MEDLINE | ID: mdl-38375029
7.
Preeclampsia and the Antiphospholipid Syndrome.
Biomedicines
; 11(8)2023 Aug 18.
Article
in English
| MEDLINE | ID: mdl-37626793
8.
Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group.
Placenta
; 136: 29-34, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37028222
9.
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Arthritis Rheumatol
; 75(10): 1687-1702, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37635643
10.
Chronic Kidney Disease and Pregnancy. Guideline of the DGGG, OEGGG, DGfN (S2k Level, AWMF Registry No. 015â-â090).
Geburtshilfe Frauenheilkd
; 82(8): 795-830, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35967745
11.
Comparison of mean platelet volume (MPV) and sFlt-1/PlGF ratio as predictive markers for preeclampsia.
J Matern Fetal Neonatal Med
; 34(9): 1407-1414, 2021 May.
Article
in English
| MEDLINE | ID: mdl-31257953
12.
Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases.
J Reprod Immunol
; 138: 103101, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32114217
13.
Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study.
RMD Open
; 6(2): 0, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32848089
14.
Changes of platelet count throughout pregnancy in women with antiphospholipid syndrome.
J Reprod Immunol
; 136: 102612, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31542513
15.
Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia.
J Clin Med
; 8(9)2019 Sep 10.
Article
in English
| MEDLINE | ID: mdl-31510056
16.
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
Autoimmun Rev
; 18(4): 406-414, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30772493
17.
Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus.
J Reprod Immunol
; 127: 19-23, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29689494
18.
Comparison of two-risk assessment algorithms for preeclampsia in first trimester with consecutive intake of low-dose aspirin in the high-risk group - an observational study.
J Matern Fetal Neonatal Med
; 31(5): 549-552, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-28162023
19.
Risk assessment for preterm preeclampsia in first trimester: Comparison of three calculation algorithms.
Eur J Obstet Gynecol Reprod Biol
; 231: 241-247, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30439653
20.
Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.
Thromb Haemost
; 118(4): 639-646, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29490410